Pacific Blue™ anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_Blue_090309
C57BL/6 bone marrow cells stained with 1A8 Pacific Blue™
  • 1A8_Blue_090309
    C57BL/6 bone marrow cells stained with 1A8 Pacific Blue™
See Pacific Blue™ spectral data
Cat # Size Price Quantity Check Availability Save
127611 25 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127612 100 µg 199€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue™ under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue™ has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue™ conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gittens B, et al. 2017. J Immunol. 10.4049/jimmunol.1600709. PubMed
  2. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  3. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  4. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  5. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  6. Teo TH, et al. 2018. Nat Commun. 9:3905. PubMed
  7. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  8. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  9. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
  10. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  11. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  12. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  13. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  14. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  15. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  16. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  17. Fukushima K, et al. 2020. Immunity. 52(3):542-556. PubMed
  18. Hooftman A, et al. 2020. Cell Metabolism. 32(3):468-478. PubMed
  19. Gibbons M, et al. 2011. Am J Respir Crit Care Med. 184:569. PubMed
  20. Yan J, et al. 2012. J Immunol. 188:2316. PubMed
  21. Avila M, et al. 2012. Innate Immunity. 18:648. PubMed
  22. Hickey A, et al. 2013. Infect Immun . 81:2123. PubMed
  23. Dorward D, et al. 2013. J Leukoc Biol. 94:193. PubMed
  24. Kim K, et al. 2014. Proc Natl Acad Sci U S A. 111:11774. PubMed
  25. Her Z, et al. 2015. EMBO Mol Med. 7:24. PubMed
  26. Zhang L, et al. 2015. J Immunol. 194:5423. PubMed
  27. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  28. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  29. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  30. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  31. Bodogai M, et al. 2015. Cancer Res . 75: 3456-3465. PubMed
  32. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  33. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  34. Wang B, et al. 2015. Sci Rep. 5: 17695. PubMed
  35. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  36. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  37. Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
  38. Myers DR, et al. 2020. Front Immunol. 11:576310. PubMed
  39. Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
  40. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  41. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  42. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  43. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  44. Barkaway A, et al. 2021. Immunity. . PubMed
  45. Sutherland TE, et al. 2021. Frontiers in Immunology. 12:715209. PubMed
  46. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  47. Yu X, et al. 2021. Nature. 594:560. PubMed
  48. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  49. Arnardottir H, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  50. de Gaetano M, et al. 2021. J Med Chem. 64:9193. PubMed
  51. Honda M, et al. 2021. Nat Commun. 12:7294. PubMed
  52. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  53. Li F, et al. 2022. Mediators Inflamm. 2022:5782922. PubMed
  54. Ding P, et al. 2022. Bone Res. 10:42. PubMed
  55. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  56. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  57. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  58. Dong L, et al. 2022. Cells. 11:. PubMed
  59. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  60. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  61. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  62. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  63. Peng Y, et al. 2023. Respir Res. 24:33. PubMed
  64. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  65. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  66. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  67. Tong L, et al. 2023. Sci Adv. 9:eade5041. PubMed
RRID
AB_1877212 (BioLegend Cat. No. 127611)
AB_2251161 (BioLegend Cat. No. 127612)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 01/06/2017

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account